JPMorgan Chase & Co. Acquires 66,747 Shares of Core Laboratories Inc. (NYSE:CLB)

JPMorgan Chase & Co. boosted its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 161.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 108,028 shares of the oil and gas company's stock after buying an additional 66,747 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.23% of Core Laboratories worth $1,870,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of CLB. Geode Capital Management LLC boosted its position in shares of Core Laboratories by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company's stock worth $19,521,000 after purchasing an additional 7,721 shares during the last quarter. Boston Trust Walden Corp grew its position in shares of Core Laboratories by 2.7% during the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company's stock worth $10,686,000 after buying an additional 16,503 shares during the period. Van ECK Associates Corp increased its stake in shares of Core Laboratories by 6.3% in the 4th quarter. Van ECK Associates Corp now owns 443,621 shares of the oil and gas company's stock valued at $7,679,000 after acquiring an additional 26,237 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Core Laboratories in the 4th quarter valued at approximately $6,760,000. Finally, Principal Financial Group Inc. boosted its stake in Core Laboratories by 3.1% during the 4th quarter. Principal Financial Group Inc. now owns 229,096 shares of the oil and gas company's stock worth $3,966,000 after acquiring an additional 6,827 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have commented on CLB. StockNews.com downgraded shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Citigroup upgraded Core Laboratories from a "sell" rating to a "neutral" rating and lifted their target price for the stock from $15.00 to $16.00 in a report on Wednesday, March 12th. Finally, Stifel Nicolaus lowered their price target on Core Laboratories from $19.00 to $15.00 and set a "hold" rating for the company in a report on Tuesday, April 15th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $15.75.

Core Laboratories Stock Down 2.4 %

Shares of Core Laboratories stock traded down $0.28 during trading on Wednesday, reaching $11.44. The stock had a trading volume of 897,991 shares, compared to its average volume of 395,232. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The company has a market capitalization of $534.27 million, a price-to-earnings ratio of 17.33, a P/E/G ratio of 0.99 and a beta of 1.99. Core Laboratories Inc. has a 52 week low of $10.14 and a 52 week high of $25.13. The stock has a fifty day moving average price of $13.67 and a two-hundred day moving average price of $17.03.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The business had revenue of $123.59 million for the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. Core Laboratories's revenue was down 4.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.19 earnings per share. Sell-side analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th will be given a dividend of $0.01 per share. The ex-dividend date is Monday, May 5th. This represents a $0.04 annualized dividend and a yield of 0.35%. Core Laboratories's dividend payout ratio (DPR) is presently 6.78%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.